Insider Buy/Sell Details for the Biotechnology Industry — August 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (885)
ARDELYX, INC. (ARDX)
RAAB MICHAEL — Director
Shares
15,976
Price
$3.86
Total Value
$61.62K
Shares Held After
1,647,381
% of Holdings
1.0%
ARDELYX, INC. (ARDX)
RAAB MICHAEL — Director
Shares
15,009
Price
$3.86
Total Value
$57.89K
Shares Held After
1,663,357
% of Holdings
0.9%
OMEROS CORP (OMER)
Borges David J. — VP, Finance&CAO
Shares
10,000
Price
$18.95
Total Value
$189.50K
Shares Held After
0
% of Holdings
100.0%
Mineralys Therapeutics, Inc. (MLYS)
Warren Eric — Chief Commercial Officer
Shares
7,437
Price
$25.98
Total Value
$193.19K
Shares Held After
38,400
% of Holdings
16.2%
PRECIGEN, INC. (PGEN)
AGEE NANCY H — Director
Shares
3,411
Price
$7.23
Total Value
$24.66K
Shares Held After
309,187
% of Holdings
1.1%
PRECIGEN, INC. (PGEN)
Shah Rutul R — Chief Operating Officer
Shares
34,658
Price
$7.50
Total Value
$259.94K
Shares Held After
465,012
% of Holdings
6.9%
Allogene Therapeutics, Inc. (ALLO)
Douglas Earl Martin — SVP, General Counsel
Shares
29,697
Price
$2.12
Total Value
$62.96K
Shares Held After
488,267
% of Holdings
5.7%
Liquidia Corp (LQDA)
Adair Jason — Chief Business Officer
Shares
41,832
Price
$69.09
Total Value
$2.89M
Shares Held After
174,606
% of Holdings
19.3%
Liquidia Corp (LQDA)
Adair Jason — Chief Business Officer
Shares
31,799
Price
$69.09
Total Value
$2.20M
Shares Held After
216,438
% of Holdings
12.8%
Lyell Immunopharma, Inc. (LYEL)
Lee Gary K. — Chief Scientific Officer
Shares
1,457
Price
$15.54
Total Value
$22.64K
Shares Held After
16,220
% of Holdings
8.2%
Revolution Medicines, Inc. (RVMD)
GOLDSMITH MARK A — Director
Shares
126
Price
$212.06
Total Value
$26.72K
Shares Held After
61,424
% of Holdings
0.2%
Revolution Medicines, Inc. (RVMD)
GOLDSMITH MARK A — Director
Shares
229
Price
$211.46
Total Value
$48.43K
Shares Held After
61,550
% of Holdings
0.4%
Revolution Medicines, Inc. (RVMD)
GOLDSMITH MARK A — Director
Shares
126
Price
$210.40
Total Value
$26.51K
Shares Held After
61,779
% of Holdings
0.2%
Revolution Medicines, Inc. (RVMD)
GOLDSMITH MARK A — Director
Shares
1,405
Price
$209.27
Total Value
$294.02K
Shares Held After
61,905
% of Holdings
2.2%
Revolution Medicines, Inc. (RVMD)
GOLDSMITH MARK A — Director
Shares
937
Price
$208.36
Total Value
$195.23K
Shares Held After
63,310
% of Holdings
1.5%
Revolution Medicines, Inc. (RVMD)
GOLDSMITH MARK A — Director
Shares
177
Price
$207.25
Total Value
$36.68K
Shares Held After
64,247
% of Holdings
0.3%
Revolution Medicines, Inc. (RVMD)
GOLDSMITH MARK A — Director
Shares
127
Price
$212.06
Total Value
$26.93K
Shares Held After
61,424
% of Holdings
0.2%
Revolution Medicines, Inc. (RVMD)
GOLDSMITH MARK A — Director
Shares
245
Price
$211.47
Total Value
$51.81K
Shares Held After
61,551
% of Holdings
0.4%
Revolution Medicines, Inc. (RVMD)
GOLDSMITH MARK A — Director
Shares
136
Price
$210.40
Total Value
$28.61K
Shares Held After
61,796
% of Holdings
0.2%
Revolution Medicines, Inc. (RVMD)
GOLDSMITH MARK A — Director
Shares
1,351
Price
$209.28
Total Value
$282.74K
Shares Held After
61,932
% of Holdings
2.1%
Revolution Medicines, Inc. (RVMD)
GOLDSMITH MARK A — Director
Shares
951
Price
$208.36
Total Value
$198.15K
Shares Held After
63,283
% of Holdings
1.5%
Revolution Medicines, Inc. (RVMD)
GOLDSMITH MARK A — Director
Shares
190
Price
$207.25
Total Value
$39.38K
Shares Held After
64,234
% of Holdings
0.3%
Revolution Medicines, Inc. (RVMD)
GOLDSMITH MARK A — Director
Shares
3,621
Price
$212.08
Total Value
$767.93K
Shares Held After
267,330
% of Holdings
1.3%
Revolution Medicines, Inc. (RVMD)
GOLDSMITH MARK A — Director
Shares
6,583
Price
$211.33
Total Value
$1.39M
Shares Held After
270,951
% of Holdings
2.4%
Revolution Medicines, Inc. (RVMD)
GOLDSMITH MARK A — Director
Shares
3,813
Price
$210.25
Total Value
$801.67K
Shares Held After
277,534
% of Holdings
1.4%
Revolution Medicines, Inc. (RVMD)
GOLDSMITH MARK A — Director
Shares
35,938
Price
$209.26
Total Value
$7.52M
Shares Held After
281,347
% of Holdings
11.3%
Revolution Medicines, Inc. (RVMD)
GOLDSMITH MARK A — Director
Shares
24,917
Price
$208.37
Total Value
$5.19M
Shares Held After
317,285
% of Holdings
7.3%
Revolution Medicines, Inc. (RVMD)
GOLDSMITH MARK A — Director
Shares
5,128
Price
$207.23
Total Value
$1.06M
Shares Held After
342,202
% of Holdings
1.5%
Lyell Immunopharma, Inc. (LYEL)
Hill Stephen J. — Chief Operating Officer
Shares
989
Price
$15.54
Total Value
$15.37K
Shares Held After
16,816
% of Holdings
5.6%
Lyell Immunopharma, Inc. (LYEL)
Seely Lynn — Director
Shares
9,589
Price
$15.54
Total Value
$149.01K
Shares Held After
63,899
% of Holdings
13.0%
Revolution Medicines, Inc. (RVMD)
Cislini Jeff — General Counsel
Shares
3,314
Price
$212.06
Total Value
$702.76K
Shares Held After
55,907
% of Holdings
5.6%
Revolution Medicines, Inc. (RVMD)
Cislini Jeff — General Counsel
Shares
4,500
Price
$211.34
Total Value
$951.04K
Shares Held After
59,221
% of Holdings
7.1%
Revolution Medicines, Inc. (RVMD)
Cislini Jeff — General Counsel
Shares
2,540
Price
$210.26
Total Value
$534.07K
Shares Held After
63,721
% of Holdings
3.8%
Revolution Medicines, Inc. (RVMD)
Cislini Jeff — General Counsel
Shares
25,817
Price
$209.25
Total Value
$5.40M
Shares Held After
66,261
% of Holdings
28.0%
Revolution Medicines, Inc. (RVMD)
Cislini Jeff — General Counsel
Shares
17,323
Price
$208.37
Total Value
$3.61M
Shares Held After
92,078
% of Holdings
15.8%
Revolution Medicines, Inc. (RVMD)
Cislini Jeff — General Counsel
Shares
3,400
Price
$207.24
Total Value
$704.60K
Shares Held After
109,401
% of Holdings
3.0%
Alpha Tau Medical Ltd. (DRTS)
Levy Raphi — Chief Financial Officer
Shares
2,871
Price
$15.00
Total Value
$43.07K
Shares Held After
90,180
% of Holdings
3.1%
TENAX THERAPEUTICS, INC. (TENX)
ADAR1 Capital Management, LLC — 10% Owner
Shares
716,369
Price
$1.77
Total Value
$1.27M
Shares Held After
4,746,444
% of Holdings
15.1%
Arcus Biosciences, Inc. (RCUS)
Azoy Alexander — Chief Accounting Officer
Shares
2,827
Price
$30.00
Total Value
$84.81K
Shares Held After
39,581
% of Holdings
6.7%
Kura Oncology, Inc. (KURA)
Powl Brian T. — Chief Commercial Officer
Shares
4,345
Price
$11.89
Total Value
$51.66K
Shares Held After
169,269
% of Holdings
2.5%
Intellia Therapeutics, Inc. (NTLA)
LEONARD JOHN M — Director
Shares
2,785
Price
$13.00
Total Value
$36.20K
Shares Held After
1,147,064
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
200
Price
$527.71
Total Value
$105.54K
Shares Held After
324,443
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
45
Price
$526.47
Total Value
$23.69K
Shares Held After
324,643
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
235
Price
$525.42
Total Value
$123.47K
Shares Held After
324,688
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
625
Price
$524.35
Total Value
$327.72K
Shares Held After
324,923
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
455
Price
$523.62
Total Value
$238.25K
Shares Held After
325,548
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
669
Price
$522.29
Total Value
$349.41K
Shares Held After
326,003
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
371
Price
$521.28
Total Value
$193.40K
Shares Held After
326,672
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
440
Price
$520.03
Total Value
$228.81K
Shares Held After
327,043
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
837
Price
$519.09
Total Value
$434.47K
Shares Held After
327,483
% of Holdings
0.3%
Showing 51–100 of 885 transactions (page 2 of 18)